Clinical Trial Update: Rapid Assessment of Cardiac Markers for the Evaluation of Acute Coronary Syndrome (RACE-ACS) [Phase 4]

View source ↗

Summary

The Phase 4 RACE-ACS trial evaluating rapid assessment of cardiac markers for Acute Coronary Syndrome has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome

Snippet

Sponsor: Abbott RDx Cardiometabolic | Conditions: Acute Coronary Syndrome | Phase 4 | Status: WITHDRAWN